Non-steroidal mineralocorticoid receptor antagonist, finerenone, attenuates obesity- and hypertension-induced cardiomyocyte hypertrophy in a blood pressure-independent manner.
28 August 2023 (15:15 - 15:45)
Organised by: 
About the speaker
Kumamoto University, Kumamoto (Japan)
5 More presentations in this session
Doctor T. Harada (Yufu City, JP)
Mr Y. Stephan (Rouen, FR)
Doctor J. Rosenmeier (Gothenburg, SE)
Access the full session
The Event
ESC Congress 2023
28 August 2023
15:15 CET
You may be interested in
Congress Presentation
